Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified

DRUG2 trials

Sponsors

Grifols Therapeutics LLC

Conditions

Multiple Sclerosis, Relapsing-RemittingPurpura, Thrombocytopenic, Idiopathic

Phase 2

Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis

CompletedNCT00220779

Grifols Therapeutics LLCMultiple Sclerosis, Relapsing-Remitting

Start: 2002-12-31End: 2005-02-28Updated: 2016-04-27

Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP

CompletedNCT00220727

Grifols Therapeutics LLCPurpura, Thrombocytopenic, Idiopathic

Start: 2003-07-31End: 2003-10-31Updated: 2016-04-27